Herpes Zoster Subunit (HZ/su) Vaccine ( DrugBank: - )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 49 | 全身性エリテマトーデス | 1 |
49. 全身性エリテマトーデス
臨床試験数 : 993 / 薬物数 : 702 - (DrugBank : 184) / 標的遺伝子数 : 116 - 標的パスウェイ数 : 200
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05559671 (ClinicalTrials.gov) | February 7, 2023 | 26/9/2022 | Safety of the Herpes Zoster Subunit Vaccine in Lupus | A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Non-inferiority Crossover Study Evaluating the Safety and Immunogenicity of the Herpes Zoster Subunit Vaccine in Patients With Systemic Lupus Erythematosus | Systemic Lupus Erythematosus | Biological: Herpes Zoster Subunit (HZ/su) Vaccine;Biological: Placebo | NYU Langone Health | NULL | Not yet recruiting | 18 Years | 90 Years | All | 224 | Phase 4 | United States |